Barium fluoride

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2017-09-21 to 2018-02-16

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2018

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Version / remarks:

December 2001
*Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.tris
*EPA Health Effects Test Guidelines (OPPTS 870.1100), United States, EPA 712-C-98-190 (1998)

Deviations:

yes

Remarks:

The actual range for humidity was 33 – 80 % (instead of 30-70% in the guideline). However, these minor differences of the environmental parameters were considered not to adversely affect the results of integrity of the study

GLP compliance:

yes (incl. QA statement)

Remarks:

June 2015

Test type:

acute toxic class method

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

Barium fluoride

EC Number:

232-108-0

EC Name:

Barium fluoride

Cas Number:

7787-32-8

Molecular formula:

BaF2

IUPAC Name:

barium fluoride

Test material form:

solid: crystalline

Test animals

Species:

rat

Strain:

other: CLR:(WI) Wistar rats

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, D-97633 Sulzfeld
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 weeks old
- Weight at study initiation: 177-221g
- Fasting period before study: On the night before treatment, the animals were fasted. The food but not water was withheld during an overnight period. The food was made available again at about 3 hours after the treatment.
- Housing: standard housing conditions ; 3 animals / cage, Type II polypropylene/polycarbonate cages, “Lignoce 3/4-S Hygienic Animal Bedding” and “Arbocel crinklets natural” nest building material produced by J. Rettenmaier & Söhne GmbH & Co.KG (D-73494 Rosenberg, Germany) were available to animals during the study.
- Enrichment: Animals were housed by group to allow social interaction and with deep wood sawdust bedding to allow digging and other normal rodent activities.

- Diet: ssniff® SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest, Germany (Batch no.: 262 21592, expiry date: 31 January 2018), ad libitum
- Water : tap water from the municipal supply, as for human consumption from 500 ml bottles, ad libitum
- Acclimation period: At least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 33-80%
- Air changes (per hr): 15 – 20 air exchanges/hour
- Photoperiod (hrs dark / hrs light): 12 hours daily, from 6.00 am to 6.00 pm

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

methylcellulose

Details on oral exposure:

VEHICLE
- Concentration in vehicle: 200 or 30 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg bw
- Justification for choice of vehicle: The selection of the vehicle was made during trial formulations with the test item.
- Lot/batch no.: S11138
- Purity: 1% methylcellulose

CLASS METHOD
- Rationale for the selection of the starting dose: The starting dose was selected by the Sponsor. In the lack of any preliminary toxicological information, 300 mg/kg bw was selected to be the starting dose.

Doses:

300, 2000 mg/kg

No. of animals per sex per dose:

3

Details on study design:

- Duration of observation period following administration: 14 days

- Clinical Observations
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Individual observations were performed on the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.

- Body Weight Measurement
The body weight was recorded on the day before treatment (Day -1), on the day of the treatment (Day 0), Day 7 and Day 14.
 
- Necropsy
All animals were subjected to a necropsy and a macroscopic examination. The animals were exsanguinated after verification of narcosis following an injection of pentobarbital sodium (Euthanimal 40%; Lot No.: 1609291-03, Expiry Date: October 2019, Produced by: Alfasan International B.V.). After examination of the external appearance, the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs were observed. All gross macroscopic changes were recorded for each animal.

Statistics:

No statistics were performed.

Results and discussion

Effect levels

Sex:

female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Based on:

test mat.

Mortality:

Test item did not cause mortality at a dose level of 300 and 2000 mg/kg bw.

Clinical signs:

other: Clinical signs were noted in 6/6 animals treated at the dose level of 300 mg/kg bw and included activity decreased. Furthermore hunched back in 3/6 animals and activity decreased in 2/6 animals at the dose level of 2000 mg/kg bw were recorded. There was n

Gross pathology:

There was no evidence of the macroscopic changes at a dose level of 300 and 2000 mg/kg bw.

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

Under the conditions of this study, the acute oral LD50 value of the test item Barium fluoride was found to be above 2000 mg/kg bw in female CRL:(WI) rats.

Executive summary:

The single-dose oral toxicity of Barium fluoride was performed according to the acute toxic class method (OECD 423 and Commission Regulation (EC) No 440/2008 of 30 May2008, B.1.tris)in CRL:(WI) rats and GLP conditions. Two groups of three females were treated at the dose level of 300 mg/kg bw resulting in no mortality. Thereafter, two groups of three females were treated at the dose level of 2000 mg/kg bw also resulting in no mortality. No treatment-related adverse effects were noted. Barium fluoride was not acutely orally toxic to female rats up to 2000 mg/kg bw under the conditions of this study.